Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Exciton secures Health Canada approval

Exciton Technologies has received Health Canada approval to market the exsalt SD7 Wound Dressing within Canada, a Class II medical device which targets the treatment of serious burns and chronic wounds.

The exsalt SD7 Wound Dressing incorporates the company’s patented platform coating technology, which utilizes a unique form of silver as the active ingredient, Exciton said.

Exciton president and founder Rod Precht said with the approval from Health Canada and FDA clearance back in 2009, they can finalize their commercialization efforts to sell the exsalt SD7 Wound Dressing throughout North America.

"Health Canada approval is a significant achievement, requiring stringent ISO 13485 medical device manufacturing certification prior to filing, and paves the way for regulatory approval in other countries," Precht said.